Form 4: Director McEachin Transfers MD Shares to Trust

Pediatrix Medical Group Director Thomas McEachin transferred a total of 54,646 shares of common stock to a living trust in August 2025.

Summary

• Thomas McEachin, a Director of Pediatrix Medical Group, Inc. (MD), reported changes in his beneficial ownership of the company's common stock.
• On August 19, 2025, McEachin transferred 54,021 shares of common stock to a trust.
• On August 20, 2025, an additional 625 shares of common stock were transferred to the same trust.
• The transfers were made to a trust where McEachin and his spouse serve as trustees and beneficiaries, indicating an estate planning transaction rather than a sale.
• Following these transactions, McEachin directly owns 11,427 shares and indirectly owns 54,646 shares through the Thomas A. McEachin Living Trust dated April 17, 2025.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the transfer of shares to a trust for estate planning purposes, which is generally neutral in sentiment as it is not a sale or purchase on the open market.

Future Outlook

NA

Industry Context

NA

Key Dates

Keywords

Pediatrix Medical Group, MD, Thomas McEachin, SEC Form 4, Insider Transaction, Stock Transfer, Director, Beneficial Ownership, Trust